{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T03:11:43Z","timestamp":1776049903285,"version":"3.50.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> The metabolic routes altered in Alzheimer's disease (AD) brain are poorly understood. As the metabolic pathways are evolutionarily conserved, the metabolic profiles carried out in animal models of AD could be directly translated into human studies.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We performed untargeted Nuclear Magnetic Resonance metabolomics in hippocampus of McGill-R-Thy1-APP transgenic (Tg) rats, a model of AD-like cerebral amyloidosis and the translational potential of these findings was assessed by targeted Gas Chromatography-Electron Impact-Mass Spectrometry in plasma of participants in the German longitudinal cohort AgeCoDe.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> In rat hippocampus 26 metabolites were identified. Of these 26 metabolites, nine showed differences between rat genotypes that were nominally significant. Two of them presented partial least square-discriminant analysis (PLS-DA) loadings with the larger absolute weights and the highest Variable Importance in Projection (VIP) scores and were specifically assigned to nicotinamide adenine dinucleotide (NAD) and nicotinamide (Nam). NAD levels were significantly decreased in Tg rat brains as compared to controls. In agreement with these results, plasma of AD patients showed significantly reduced levels of Nam in respect to cognitively normal participants. In addition, high plasma levels of Nam showed a 27% risk reduction of progressing to AD dementia within the following 2.5\u00a0years, this hazard ratio is lost afterwards.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> To our knowledge, this is the first report showing that a decrease of Nam plasma levels is observed couple of years before conversion to AD, thereby suggesting its potential use as biomarker for AD progression.<\/jats:p>","DOI":"10.3389\/fmolb.2022.1067296","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T18:39:13Z","timestamp":1673030353000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Nicotinamide as potential biomarker for Alzheimer\u2019s disease: A translational study based on metabolomics"],"prefix":"10.3389","volume":"9","author":[{"given":"Mar\u00eda C.","family":"Dalmasso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn","family":"Ar\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Galeano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvina","family":"Perin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Giavalisco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela V.","family":"Martino Adami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisela V.","family":"Novack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo M.","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Claudio","family":"Cuello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffi","family":"Riedel-Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/sci3010016","article-title":"Probable causes of Alzheimer\u2019s disease","volume":"3","author":"Adams","year":"2021","journal-title":"Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/fcp.12654","article-title":"The contributions of metabolomics in the discovery of new therapeutic targets in Alzheimer's disease","volume":"35","author":"Altine-Samey","year":"2021","journal-title":"Fundam. Clin. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3389\/fonc.2020.00358","article-title":"NAMPT and NAPRT: Two metabolic enzymes with key roles in inflammation","volume":"10","author":"Audrito","year":"2020","journal-title":"Front. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/tpj.12080","article-title":"Systemic analysis of inducible target of rapamycin mutants reveal a general metabolic switch controlling growth in Arabidopsis thaliana","volume":"73","author":"Caldana","year":"2013","journal-title":"Plant J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"W486","DOI":"10.1093\/nar\/gky310","article-title":"MetaboAnalyst 4.0: Towards more transparent and integrative metabolomics analysis","volume":"46","author":"Chong","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00401-010-0666-1","article-title":"Accumulation of intraneuronal Abeta correlates with ApoE4 genotype","volume":"119","author":"Christensen","year":"2010","journal-title":"Acta Neuropathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/rej.2018.2077","article-title":"The plasma NAD+ metabolome is dysregulated in \"normal\" aging","volume":"22","author":"Clement","year":"2019","journal-title":"Normal\" Aging. Rejuvenation Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of alzheimer's disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"B9","first-page":"27","article-title":"Treatment of alzheimer's disease with stabilized oral nicotinamide adenine dinucleotide: A randomized, double-blind study","volume":"30","author":"Demarin","year":"2004","journal-title":"Drugs Exp. Clin. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neurobiolaging.2022.04.009","article-title":"Principal components from untargeted cerebrospinal fluid metabolomics associated with Alzheimer's disease biomarkers","volume":"117","author":"Dong","year":"2022","journal-title":"Neurobiol. Aging."},{"key":"B11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3233\/JAD-190408","article-title":"Global metabolic shifts in age and alzheimer's disease mouse brains pivot at NAD+\/NADH redox sites","volume":"71","author":"Dong","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11357-019-00052-8","article-title":"Age- and AD-related redox state of NADH in subcellular compartments by fluorescence lifetime imaging microscopy","volume":"41","author":"Dong","year":"2019","journal-title":"GeroScience"},{"key":"B13","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.molmed.2017.08.001","article-title":"NAD(+) in aging: Molecular mechanisms and translational implications","volume":"23","author":"Fang","year":"2017","journal-title":"Trends Mol. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e75091","DOI":"10.1371\/journal.pone.0075091","article-title":"Increased neurofilament light chain blood levels in neurodegenerative neurological diseases","volume":"8","author":"Gaiottino","year":"2013","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fnbeh.2014.00321","article-title":"Longitudinal analysis of the behavioral phenotype in a novel transgenic rat model of early stages of Alzheimer's disease","volume":"8","author":"Galeano","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrendo.2015.117","article-title":"Physiological and pathophysiological roles of NAMPT and NAD metabolism","volume":"11","author":"Garten","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1523\/JNEUROSCI.6192-11.2012","article-title":"A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons","volume":"32","author":"Ghosh","year":"2012","journal-title":"J. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.neurobiolaging.2012.12.005","article-title":"Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-\u03b3 coactivator 1\u03b1 regulated \u03b2-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models","volume":"34","author":"Gong","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"B19","doi-asserted-by":"publisher","first-page":"585873","DOI":"10.3389\/fnagi.2020.585873","article-title":"Early long-term memory impairment and changes in the expression of synaptic plasticity-associated genes, in the McGill-R-Thy1-APP rat model of alzheimer's-like brain amyloidosis","volume":"12","author":"Habif","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/2051-5960-2-61","article-title":"Intracellular A\u03b2 pathology and early cognitive impairments in a transgenic rat overexpressing human amyloid precursor protein: A multidimensional study","volume":"2","author":"Iulita","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B22","volume-title":"Survminer: Drawing survival curves using 'ggplot2","author":"Kassambara","year":"2021"},{"key":"B23","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","article-title":"NAD(+) in brain aging and neurodegenerative disorders","volume":"30","author":"Lautrup","year":"2019","journal-title":"Cell Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3233\/JAD-2010-1349","article-title":"A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment","volume":"20","author":"Leon","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nprot.2006.59","article-title":"Gas chromatography mass spectrometry-based metabolite profiling in plants","volume":"1","author":"Lisec","year":"2006","journal-title":"Nat. Protoc."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.neurobiolaging.2012.11.020","article-title":"Nicotinamide forestalls pathology and cognitive decline in alzheimer mice: Evidence for improved neuronal bioenergetics and autophagy procession","volume":"34","author":"Liu","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"B27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.bbadis.2016.12.014","article-title":"Worsening of memory deficit induced by energy-dense diet in a rat model of early-Alzheimer's disease is associated to neurotoxic A\u03b2 species and independent of neuroinflammation","volume":"1863","author":"Martino Adami","year":"","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/0271678X15615132","article-title":"Synaptosomal bioenergetic defects are associated with cognitive impairment in a transgenic rat model of early Alzheimer's disease","volume":"37","author":"Martino Adami","year":"","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/wnl.34.7.939","article-title":"Clinical diagnosis of alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jare.2021.08.003","article-title":"Nicotinamide mononucleotide (NMN) as an anti-aging health product - promises and safety concerns","volume":"37","author":"Nadeeshani","year":"2021","journal-title":"J. Adv. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1021\/acs.analchem.7b04089","article-title":"NMR-guided mass spectrometry for absolute quantitation of human blood metabolites","volume":"90","author":"Nagana Gowda","year":"2018","journal-title":"Anal. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/jnc.12003","article-title":"Altered neurochemical profile in the McGill-R-Thy1-APP rat model of alzheimer's disease: A longitudinal in vivo 1 H MRS study","volume":"123","author":"Nilsen","year":"2012","journal-title":"J. Neurochem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11064-013-1222-x","article-title":"Early differences in dorsal hippocampal metabolite levels in males but not females in a transgenic rat model of Alzheimer's disease","volume":"39","author":"Nilsen","year":"","journal-title":"Neurochem. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/jcbfm.2014.37","article-title":"Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer's disease","volume":"34","author":"Nilsen","year":"","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0006-8993(03)03219-0","article-title":"Elevated neurofilament levels in neurological diseases","volume":"987","author":"Norgren","year":"2003","journal-title":"Brain Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/1471-2105-14-338","article-title":"MetSizeR: Selecting the optimal sample size for metabolomic studies using an analysis based approach","volume":"14","author":"Nyamundanda","year":"2013","journal-title":"BMC Bioinforma."},{"key":"B37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12929-019-0527-8","article-title":"Implications of altered NAD metabolism in metabolic disorders","volume":"26","author":"Okabe","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"021","DOI":"10.23937\/2469-5858\/1510021","article-title":"Phase II clinical trial of nicotinamide for the treatment of mild to moderate alzheimer's disease","volume":"3","author":"Phelan","year":"2017","journal-title":"J. Geriatr. Med. Gerontol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s007020070011","article-title":"No evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia","volume":"107","author":"Rainer","year":"2000","journal-title":"J. Neural Transm."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3233\/JAD-141521","article-title":"Elevated HbA1c is associated with increased risk of incident dementia in primary care patients","volume":"44","author":"Ramirez","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fnagi.2020.00255","article-title":"Nicotinamide, a poly [ADP-Ribose] polymerase 1 (PARP-1) inhibitor, as an adjunctive therapy for the treatment of alzheimer's disease","volume":"12","author":"Salech","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"B42","volume-title":"A package for survival analysis in R","author":"Therneau","year":"2020"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD\u207a in aging, metabolism, and neurodegeneration","volume":"350","author":"Verdin","year":"2015","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J. Stat. Softw."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e2102344118","DOI":"10.1073\/pnas.2102344118","article-title":"Genome-scale metabolic network reconstruction of model animals as a platform for translational research","volume":"118","author":"Wang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B46","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3389\/fneur.2017.00719","article-title":"Application of metabolomics in alzheimer's disease","volume":"8","author":"Wilkins","year":"2017","journal-title":"Front. Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/cercor\/bhv332","article-title":"Intraneuronal amyloid beta accumulation disrupts hippocampal CRTC1-dependent gene expression and cognitive function in a rat model of alzheimer disease","volume":"27","author":"Wilson","year":"","journal-title":"Cereb. Cortex"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2174\/1567205015666180904154446","article-title":"Microdose lithium NP03 diminishes pre-plaque oxidative damage and neuroinflammation in a rat model of alzheimer's-like amyloidosis","volume":"15","author":"Wilson","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e1190","DOI":"10.1038\/tp.2017.169","article-title":"BACE1 inhibition by microdose lithium formulation NP03 rescues memory loss and early stage amyloid neuropathology","volume":"7","author":"Wilson","year":"","journal-title":"Transl. Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.3892\/mmr.2019.10782","article-title":"Nicotinamide phosphoribosyltransferaserelated signaling pathway in early Alzheimer's disease mouse models","volume":"20","author":"Xing","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"530219","DOI":"10.3389\/fnins.2020.530219","article-title":"Metabolic dysregulation contributes to the progression of alzheimer's disease","volume":"14","author":"Yan","year":"2020","journal-title":"Front. Neurosci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1017\/s0033291700014811","article-title":"SIDAM--A structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R","volume":"21","author":"Zaudig","year":"1991","journal-title":"Psychol. Med."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.1067296\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T18:39:16Z","timestamp":1673030356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.1067296\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":52,"alternative-id":["10.3389\/fmolb.2022.1067296"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2022.1067296","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"article-number":"1067296"}}